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Murine gammaherpesvirus 68 (MHV-68) is closely related to Epstein-Barr virus and Kaposi’s sarcoma-
associated herpesvirus (KSHV) and provides a small-animal model to study the pathogenesis of gammaher-
pesvirus (HV) infections. According to the colinear organization of the HV genomes, the M10 locus is
situated at a position equivalent to the K12 locus of KSHV, which codes for proteins of the kaposin family. The
M10 locus of MHV-68 has been predicted to code for three overlapping open reading frames (M10a, M10b, and
M10c [M10a-c]) with unknown function. In addition, the M10 locus contains a lytic origin of replication
(oriLyt). To elucidate the function of the M10 locus during lytic and latent infections, we investigated, both in
vitro and in vivo, the following four recombinant viruses which were generated using MHV-68 cloned as a
bacterial artificial chromosome: (i) a mutant virus with a deletion which affects both the coding region for
M10a-c and the oriLyt; (ii) a revertant virus in which both the M10a-c coding region and the oriLyt were
reverted to those of the wild type; (iii) a virus with an ectopic insertion of the oriLyt, which restores the function
of the oriLyt but not the M10a-c coding region; and (iv) a mutant virus with a deletion in the oriLyt only. While
the mutants were slightly attenuated with regard to lytic replication in cell culture, they showed severe growth
defects in vivo. Both lytic replication and latency amplification were strongly reduced. In contrast, both the
revertant virus and the virus with the ectopic oriLyt insertion grew very similarly to the parental wild-type virus
both in vitro and in vivo. Thus, we provide genetic evidence that mutation of the oriLyt, and not of putative
protein coding sequences within the M10a-c region, is responsible for the observed phenotype. We conclude
that the oriLyt in the M10 locus plays an important role during infection of mice with MHV-68.
Diseases caused by gammaherpesviruses continue to be a
challenge for human health. The prototypic gamma-1 herpes-
virus Epstein-Barr virus (EBV) is associated with lymphomas
and nasopharyngeal carcinoma (22). Human herpesvirus 8
(also called Kaposi’s sarcoma-associated herpesvirus [KSHV]),
a gamma-2 herpesvirus, is associated with lymphoproliferative
disorders and Kaposi’s sarcoma (24). In vivo studies of gam-
maherpesvirus pathogenesis have been limited to clinical in-
vestigation of the infection because of the restricted host range
of these viruses. The murine gammaherpesvirus 68 (MHV-68)
is also a member of the gammaherpesvirus subfamily and is
closely related to KSHV and EBV. Since there exist no good
animal models for KSHV and EBV, MHV-68 serves as a
small-animal model to investigate gammaherpesvirus patho-
genesis (6, 9, 10, 13, 21, 25, 26, 30). MHV-68 is a natural
pathogen of wild rodents (7) and is capable of infecting labo-
ratory mice. The nucleotide sequence of MHV-68 is similar to
that of EBV and even more closely related to that of KSHV
(29). MHV-68 contains genes which are homologous to cellu-
lar genes or to genes of other gammaherpesviruses. In addi-
tion, it contains virus-specific genes. Many of the latency- and
transformation-associated proteins of the gammaherpesvi-
ruses, for example, EBNA and LMP of EBV, appear to be
encoded by virus-specific genes, yet it has been suggested that
pathogenesis-associated genes of gammaherpesviruses may be
contained in similarly positioned genome regions (29). The
virus-specific genes of MHV-68 were originally designated M1
to M14 (29). The M10 locus has been predicted to code for
three overlapping open reading frames (M10a, M10b, and
M10c [M10a-c]) (29). While several MHV-68-specific genes
have been shown to code for proteins with important functions,
the function of M10 is still unknown. A more recent report
even considered M10a-c rather unlikely to code for proteins
(21). Importantly, the M10 locus also contains a lytic origin of
replication (oriLyt) (3, 8). According to the colinear organiza-
tion of the gammaherpesvirus genomes, the M10 locus is sit-
uated at a position equivalent to that of the K12 locus of
KSHV. K12 encodes proteins of the kaposin family. Kaposin
proteins are involved in cellular transformation and in stabili-
zation of cytokine mRNAs (16–18,20). Of note, the K12 locus
also contains an oriLyt (5).
Here, we investigated the function of the M10 locus during
lytic and latent infections by studying mutant viruses with de-
letions in the M10 loci, either affecting both the coding region
for M10a-c and the oriLyt or the oriLyt only. While the mu-
tants were slightly attenuated with regard to lytic replication in
cell culture, they showed severe growth defects in vivo. Both
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lytic replication and latency amplification were strongly re-
duced in mice infected with the mutant viruses. In contrast, a
revertant virus in which both the M10a-c coding region and the
oriLyt were reverted to those of the wild type and a virus with
an ectopic insertion of the oriLyt which restores the function of
the oriLyt but not the M10a-c coding region grew very similarly
to the parental wild-type virus both in vitro and in vivo. Thus,
we provide genetic evidence that mutation of the oriLyt, and
not of putative protein coding sequences within the M10a-c
region, is responsible for the observed phenotype.
MATERIALS AND METHODS
Cell lines. BHK-21 cells were grown in Glasgow minimal essential medium
(Biochrom AG, Berlin, Germany) supplemented with 5% fetal calf serum (FCS),
5% tryptose phosphate broth, 2 mM L-glutamine, 100 U/ml penicillin, and 100
g/ml streptomycin. Ref-Cre cells were maintained in high-glucose Dulbecco’s
minimal essential medium (Cell Concepts, Umkirch, Germany) supplemented
with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin,
and G418. NIH 3T3 cells were grown in high-glucose Dulbecco’s minimal es-
sential medium (Cell Concepts, Umkirch, Germany) supplemented with 10%
FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin.
Plasmid construction. For this study, we constructed the following four dif-
ferent versions of recombinant MHV-68. (i) The mutant virus M10Tet was
created by ET cloning (2, 34). For this purpose, the M10 region of MHV-68 was
first replaced with a tetracycline (Tet) resistance gene flanked by FLP recombi-
nation target sites. Subsequently, the Tet resistance cassette was removed by
FLP-mediated recombination, resulting in a deletion between nucleotides 99002
and 101315, which disrupts both the M10a-c coding region and the oriLyt. The
procedure left a small residual insert consisting of an FLP recombination target
site and short vector sequences in the disrupted region. (ii) To exclude the
possibility that the observed results were due to rearrangements outside the
mutated region, a revertant of the M10Tet mutant (M10.Revertant) was
generated by the two-step mutagenesis procedure (2, 19), using an unmutated
8.4-kb HindIII fragment of MHV-68 (nucleotides 95677 to 104034). (iii) We
constructed a recombinant virus (OriLytM10Tet) with an ectopic insertion of
the oriLyt, which restores the oriLyt but not the M10a-c coding region. For that
purpose, an 863-bp SmaI-EagI fragment of MHV-68 (nucleotide positions
101139 to 102002) was cloned blunt ended into the BglII site (nucleotide position
3846 of the MHV-68 genome) of the plasmid pST76K-SR M1/M2 (12). As a
result, the 863-bp fragment is flanked on both sides by homologous sequences
(positions 2406 to 3846 as the 5-end flank and positions 3847 to 6261 as the
3-end flank) as needed for homologous recombination during the two-step
mutagenesis procedure. (iv) Finally, to evaluate the impact of the oriLyt located
in the M10 region, we analyzed a mutant with a deletion which renders the oriLyt
nonfunctional but leaves the M10a-c coding region intact. The construction of
this mutant (201nt), lacking nucleotide positions 101530 to 101731, has been
described previously (3). In that work, this mutant was called mutant A
(101530-101731).
Reconstitution and characterization of recombinant MHV-68. To reconstitute
recombinant MHV-68, BHK-21 cells were transfected with 2.5 g of bacterial
artificial chromosome (BAC) MHV-68 DNA using SuperFect transfection re-
agent (Qiagen). When cells showed a total cytopathic effect (CPE), an aliquot of
the supernatant was used to infect Ref-Cre cells carrying the Cre recombinase to
remove the BAC cassette, including the green fluorescent protein sequence.
BAC cassette-free viruses were identified by a limiting dilution assay on BHK-21
cells performed in a 96-well plate. All recombinant viruses were grown and
titrated on BHK-21 cells, as previously described (2). Briefly, stocks were grown
by infecting BHK-21 cells. After a complete CPE was shown, BHK-21 cells were
harvested, and the supernatant was used as a working stock after freezing-
thawing the cells two times and removing cell debris by centrifugation. Virus
titers were determined by plaque assay. Briefly, 10-fold-higher dilutions were
incubated on BHK-21 cells for 90 min at 37°C. After the inoculum was removed,
cells were incubated for 5 days at 37°C with fresh medium containing methyl-
cellulose. Cells were stained with crystal violet solution to determine the number
of plaques.
All versions of recombinant MHV-68 were characterized by restriction enzyme
analysis with different restriction enzymes and Southern blot analysis. To test in
vitro growth, NIH 3T3 cells were infected at a multiplicity of infection (MOI) of
0.1 for 1 h. After the inoculum was removed, cells were incubated with fresh
medium at 37°C and 5% CO2 until the supernatants together with the cells were
harvested at different time points after infection. Virus titers were determined by
plaque assay, as described above.
In vivo experiments. C57BL/6 mice were purchased from Charles River Lab-
oratories (Sulzfeld, Germany) and housed in individually ventilated cages during
the MHV-68 infection period. To characterize the recombinant MHV-68 in vivo,
mice were either infected intranasally (i.n.) or intraperitoneally (i.p.) with the
indicated amounts of virus. Prior to i.n. infection, mice were anesthetized with
ketamine and xylazine. To determine virus titers, organs were harvested at the
indicated time points after infection and homogenized by Dounce homogeniza-
tion or using the FastPrep-24 instrument (MP Biomedicals, Heidelberg, Ger-
many). After freezing and thawing the homogenates two times, plaque assays
were performed with 10-fold-higher dilutions of the supernatants on BHK-21
cells, as described above. For determination of the spleen weight, frequency of
virus reactivation, and genomic load, spleens were harvested at the indicated
time points after infection.
Limiting dilution reactivation assay. To determine the frequency of cells
carrying virus reactivating from latency, threefold-higher dilutions of splenocytes
(starting with 1.5  105 cells/well) were plated onto NIH 3T3 cells (104 cells/
well), as described previously (1). The presence of preformed infectious virus was
determined by plating parallel samples of mechanically disrupted cells (latent
virus cannot reactivate from killed cells). Frequencies of reactivating cells were
calculated on the basis of the Poisson distribution by determining the cell num-
ber at which 63.2% of the wells scored positive for a CPE.
Measurement of latent viral load by quantitative real-time PCR. Viral load in
the spleens of infected mice was determined by quantitative real-time PCR using
the ABI 7300 real-time PCR system (Applied Biosystems, Foster City, CA).
DNA was extracted from spleen cells using the QIAamp DNA minikit (Qiagen,
Hilden, Germany) and quantified by UV spectrophotometry. Amplification of
100 ng of DNA per reaction was performed with TaqMan universal PCR master
mix under universal cycling conditions (Applied Biosystems, Foster City, CA).
Using primers and probes as described previously (32), a 70-bp region of the
MHV-68 glycoprotein B (gB) gene was amplified, and viral DNA copy numbers
were quantified. A standard curve was created using known amounts of a plasmid
containing the HindIII-N fragment of MHV-68 encompassing the gB gene. The
murine ribosomal protein L8 (rpl8) was amplified in parallel and used to nor-
malize for input DNA between samples. The primer and probe sequences for L8
were as follows: forward, 5-CATCCCTTTGGAGGTGGTA-3; reverse, 5-CA
TCTCTTCGGATGGTGGA-3; and probe, 5-ACCACCAGCACATTGGCAA
ACC-3. A standard curve for rpl8 was generated by a serial 10-fold-higher
dilution of a plasmid containing rpl8 (RZPD clone IRAVp968B01123D6;
RZPD, Berlin, Germany). The data are presented as viral genome copy numbers
relative to the copy number of L8. The quantification limit was set at 50 copies
per sample, according to published recommendations (28).
Statistical methods. If not otherwise indicated, data were analyzed by Stu-
dent’s t test.
RESULTS
Construction and characterization of the M10Tet mu-
tant and the M10Tet revertant. To elucidate the function of
the M10 locus during lytic and latent infections, we first con-
structed two recombinant viruses using MHV-68 cloned as a
BAC (Fig. 1A, top and middle). In the M10Tet mutant, the
deletion affects both the coding region for M10a-c and the
oriLyt. To prove that the phenotype of the M10Tet mutant
is due to the deletion and not due to rearrangements outside
the mutated region, a revertant virus was generated by replac-
ing the mutant fragment with a wild-type genomic fragment
which reverts both the M10a-c coding region and the oriLyt to
those of the wild type. The BAC-cloned genomes were ana-
lyzed by restriction enzyme analysis with several restriction
enzymes and, in some cases, by sequencing the mutated region
(data not shown). The genomes of the reconstituted recombi-
nant viruses were analyzed by restriction enzyme analysis and
Southern blotting (Fig. 1B).
The M10Tet mutant shows a slight replication deficit in
cell culture. To analyze the in vitro growth of the recombinant
viruses, multistep growth curves were performed on NIH 3T3
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cells. Compared to the parental virus, the M10Tet mutant
showed a replication deficit of approximately 1 order of mag-
nitude. In contrast, the revertant virus attained titers similar to
those of the parental virus (Fig. 2). Thus, the deletion present
in the M10Tet mutant affects lytic replication in vitro.
Reduced lytic replication in the lungs after i.n. infection
with the M10Tet mutant. To analyze lytic replication in
vivo, C57BL/6 mice were i.n. infected, and viral titers were
determined in lung homogenates by plaque assay. First, viral
titers were determined 6 days after infection, the time point
FIG. 1. Construction and characterization of the M10Tet and 201nt mutants. (A) Scheme of the mutants generated. “P” indicates the
probe used for Southern blot analysis, corresponding to nucleotides 102215 to 103164. The construction and characterization of the 201nt mutant
have been described in detail previously (3). The boxed “” schematically represents the deletion. ORF, open reading frame. (B) Southern blot
analysis of viral DNA digested with the restriction enzyme PstI and hybridized with probe P. The expected fragments are indicated by arrows on
the right. Marker sizes (in kilobase pairs) are indicated on the left.
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when peak viral titers are usually reached. Viral titers were
significantly lower after infection with the M10Tet mutant
than after infection with the parental and revertant viruses
(Fig. 3A). Importantly, the viral titer in the lungs of mice
infected with the M10 revertant virus was not significantly
different than the viral titer in the lungs of mice infected with
the parental virus, clearly indicating that the observed pheno-
type of the M10Tet mutant is due to the deletion in the M10
region and not to rearrangements outside of the mutated re-
gion. Second, we compared lytic replication of the M10Tet
mutant and that of the parental virus in the lungs of mice over
time after infection (Fig. 3B). At both days 3 and 6 after
infection, viral titers were significantly lower after infection
with the M10Tet mutant than after infection with the pa-
rental virus. At day 10 after infection, both viruses were unde-
tectable. We conclude from these data that the deletion
present in the M10Tet mutant affects lytic replication in the
lungs of mice after i.n. infection.
The M10 region is important for latency amplification in the
spleen after i.n. infection. To analyze the role of the M10
region during the latent phase of infection, C57BL/6 mice were
i.n. infected, and the extent of splenomegaly, the extent of ex
vivo reactivation of latently infected splenocytes, and the viral
genomic load in the spleen were determined. First, we ana-
lyzed these parameters 17 days after infection, a time point
around the peak of latency amplification. The spleen weight of
mice infected with the M10Tet mutant was significantly
lower than the spleen weight of mice infected with the parental
and revertant viruses (Fig. 4A). In addition to the spleen
weight, we also determined the number of reactivating spleno-
cytes in an ex vivo reactivation assay. Serial dilutions of live,
intact splenocytes were plated on NIH 3T3 indicator cells in
parallel with samples that were mechanically disrupted to dis-
tinguish between virus reactivation from latency and pre-
formed infectious virus. No preformed infectious virus was
detected for any of the viruses analyzed (data not shown).
Significantly less splenocytes from mice infected with the
M10Tet mutant were reactivated compared to those in-
fected with the parental and revertant viruses (Fig. 4B). The
FIG. 2. Replication in cell culture. NIH 3T3 cells were infected at
an MOI of 0.1 with the indicated viruses. Cells were harvested at
different time points after infection, and titers were determined on
BHK-21 cells. Data shown are the means  standard deviations from
three independent experiments.
FIG. 3. Lytic replication in the lungs after i.n. infection. C57BL/6 mice were infected i.n. with 5  104 PFU of the indicated viruses. At day 6
after infection (A) or at the indicated time points (B), lungs were harvested, and virus titers were determined from organ homogenates by plaque
assay on BHK-21 cells. Each symbol represents an individual mouse, and the bars represent the means. (A) The data are compiled from seven
(parental virus), eight (M10Tet), two (201nt), and five (M10.Revertant) independent experiments; (B) the data are from a single experiment.
The asterisks indicate a statistically significant difference between mutant viruses and parental and revertant viruses (P  0.001) (A) and between
mutant virus and parental virus (P  0.003 at day 3 and P  0.047 at day 6) (B).
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frequency of reactivating splenocytes was 1 in 16.964 for the
parental virus and 1 in 23.521 for the revertant virus. In con-
trast, the reactivation events for the M10Tet mutant did not
reach the point of 63.2% Poisson distribution and thus were
too low to calculate the frequency of cells reactivating lytic
replication. Using real-time PCR, we determined the genomic
load in the spleens of infected mice. Consistent with the data
from the ex vivo reactivation assay, the viral copy number of
mice infected with the M10Tet mutant was also significantly
lower than the copy number of those infected with the parental
and revertant viruses (Fig. 4C). These data indicate that the
observed defect is due to a lower number of infected cells and
not to a defect in reactivation. Importantly, all three parameters
were not significantly different in mice infected with the M10
revertant virus when compared to the parental virus, again clearly
indicating that the observed phenotype of the M10Tet mutant
is due to the deletion in the M10 region and not to rearrange-
ments outside of the mutated region. Additionally, we com-
pared the genomic load in the spleens of infected mice at two
additional time points. At day 10 after infection, a time point
when latency establishment takes place, the genomic load in
mice infected with the M10Tet mutant was considerably
lower than that in mice infected with either parental virus or
revertant virus (Fig. 4D). However, the difference did not
FIG. 4. Latent infection in the spleen after i.n. infection. (A) Spleen weights; (B) ex vivo reactivation of splenocytes; (C and D) viral genomic
load in the spleen. C57BL/6 mice were infected i.n. with 5 104 PFU of the indicated viruses. At day 17 (A to C) or at days 10 and 42 after infection
(D), spleens were harvested, and the spleen weights were taken. Single splenocyte suspensions were prepared and analyzed in the ex vivo
reactivation assay or used for DNA isolation for real-time PCR analysis. Data shown in panel A are the means standard deviations of the number
of individual mice indicated, compiled from nine (parental virus; M10Tet), two (201nt), and four (M10.Revertant) independent experiments.
The means standard deviations of three uninfected mice are shown for comparison. The asterisks indicate a statistical significant difference (P
3.3 10	16 [parental virus versus M10Tet]; P 1.6 10	5 [parental virus versus 201nt]; P 2.2 10	14 [M10Tet versus M10.Revertant];
and P 0.0003 [201nt versus M10.Revertant]). Data shown in panel B are the means standard errors of the means pooled from eight (parental
virus), nine (M10Tet), two (201nt), and four (M10.Revertant) independent experiments. In each experiment, splenocytes from three mice per
group were pooled. The dashed line in panel B indicates the point of 63.2% Poisson distribution, determined by nonlinear regression, which was
used to calculate the frequency of cells reactivating lytic replication. To calculate significance, frequencies of reactivation events were statistically
analyzed by paired t test for all cell dilutions. The statistical significance is indicated by P values of 0.027 (parental virus versus M10Tet), 0.021
(parental virus versus 201nt), 0.022 (M10Tet versus M10.Revertant), and 0.018 (201nt versus M10.Revertant). In panels C and D, each
symbol represents an individual mouse, and the bars represent the means. The data in panel C are compiled from eight (parental virus), nine
(M10Tet), three (201nt), and three (M10.Revertant) independent experiments, and the data in panel D are from a single experiment. The
asterisks in panel C indicate statistical significance: P values of 8  10	7 (parental virus versus M10Tet), 0.01 (parental virus versus 201nt),
8  10	6 (M10Tet versus M10.Revertant), and 0.024 (201nt versus M10.Revertant).
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reach statistical significance due to the small number of mice
tested and the variability between individual mice. At day 42
after infection, the genomic loads were comparable in all
groups of mice. Thus, taking all three independent measure-
ments of viral latency together, we conclude that the deletion
present in the M10Tet mutant does also influence latency
after i.n. infection.
Lytic replication and latency in the spleen are also reduced
after i.p. infection with the M10Tet mutant. Since it has
been described that the phenotype of MHV-68 mutants may
depend on the route used for infection (15), we also analyzed
the phenotype of the M10Tet mutant after i.p. infection.
For this purpose, mice were infected i.p. with 1  105 PFU of
either parental virus or the M10Tet mutant. First, spleens
were harvested 6 days after infection, and lytic virus titers were
determined from organ homogenates by plaque assay. Lytic
virus was detected in all mice after infection with the parental
virus. However, no virus was detected after infection with the
M10Tet mutant (Fig. 5A). It should be noted that after i.p.
infection, the peak of acute infection in the spleen is around
day 9 after infection (31). Thus, it is likely that at a later time
point, lytic virus would also be detectable in mice infected i.p.
with the M10Tet mutant. Nevertheless, the data clearly
indicate that the deletion present in the M10Tet mutant
also affects lytic replication after i.p. infection. Second, spleens
were harvested 17 days after infection and analyzed by the ex
vivo reactivation assay (Fig. 5B). As after i.n. infection, less
splenocytes reactivated from mice infected with the M10Tet
mutant than from mice infected with the parental virus. The
frequency of reactivating splenocytes was 1 in 57.094 for
the parental virus. In contrast, the reactivation events for the
M10Tet mutant did not reach the point of the 63.2% Pois-
son distribution and thus were too low to calculate the fre-
quency of cells reactivating lytic replication. No preformed
infectious virus was detected for any of the viruses analyzed
(data not shown). The data shown in Fig. 5B are from a single
experiment only (with pooled splenocytes from three mice per
group). However, the experiment was repeated twice with two
additional infection doses (1  106 and 1  104 PFU), which
yielded comparable results (data not shown). Thus, the dele-
tion present in the M10Tet mutant also influences latency
after i.p. infection.
Ectopic complementation of the oriLyt restores the pheno-
type of the M10Tet mutant. Since (i) others considered
M10a-c unlikely to code for proteins (21) and (ii) we were not
able to detect M10 proteins (data not shown; see Discussion), we
hypothesized that the observed phenotype of the M10Tet mu-
tant might be due to the mutation in the oriLyt. As described
above, in the M10Tet mutant, both the coding region for
M10a-c and the oriLyt are mutated. Thus, a virus with a mutated
M10 region but an intact oriLyt should behave like the parental
virus if the observed phenotype is due to mutation of the oriLyt
and not the putative protein coding sequences within the M10a-c
region. To test this hypothesis, we ectopically inserted an 863-bp
fragment, containing the entire essential region of the oriLyt, into
the M10Tet mutant, thereby restoring the function of the
oriLyt but not the M10a-c coding region in the resulting virus
OriLytM10Tet (Fig. 6A and B).
First, we analyzed the in vitro growth of the OriLytM10Tet
virus. For this purpose, multistep growth curves were generated
from NIH 3T3 cells. As shown before, the M10Tet mutant
showed a replication deficit of approximately 1 order of magni-
tude compared to that of the parental virus. In contrast, the
OriLytM10Tet virus attained titers similar to those of the
FIG. 5. Lytic replication and latent infection in the spleen after i.p. infection. C57BL/6 mice were infected i.p. with 1 105 PFU of the indicated
viruses. (A) Spleen titer. At day 6 after infection, spleens were harvested, and virus titers were determined from organ homogenates by plaque assay
on BHK-21 cells. Each symbol represents an individual mouse, and the bar represents the mean. The data were compiled from two independent
experiments. The asterisk indicates a statistically significant difference (P 0.001). (B) Ex vivo reactivation of splenocytes. At day 17 after infection,
spleens were harvested, and single splenocyte suspensions were prepared and analyzed in the ex vivo reactivation assay. Data shown are the means
from a single experiment, with pooled splenocytes from three mice per group. The dashed line indicates the point of 63.2% Poisson distribution,
determined by nonlinear regression, which was used to calculate the frequency of cells reactivating lytic replication. To calculate significance,
frequencies of reactivation events were statistically analyzed by paired t test for all cell dilutions. The statistical significance of the difference
between the mutant and parental viruses is a P value of 0.07.
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FIG. 6. Construction and characterization of the OriLytM10Tet mutant. (A) Schematic map of the OriLytM10Tet mutant genome, with
the ectopic insertion of the essential part of the oriLyt indicated. P, probe. (B) Southern blot analysis of viral DNA digested with the restriction
enzyme SacI and hybridized with the 863-bp SmaI-EagI fragment, indicated in panel A as the probe. The expected fragments are indicated by
arrows on the right. Marker sizes (in kilobase pairs) are indicated on the left.
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parental virus (Fig. 7). Thus, ectopic insertion of the oriLyt com-
pletely restores the in vitro phenotype of the M10Tet mutant.
Next, we analyzed lytic replication in vivo. C57BL/6 mice
were i.n. infected, and viral titers were determined in lung
homogenates by plaque assay 6 days after infection. Consistent
with the previous results, the M10Tet mutant showed a
significant replication deficit. However, ectopic insertion of the
oriLyt completely restored the phenotype of the M10Tet
mutant (Fig. 8A). Finally, we analyzed the latent phase after
infection with the OriLytM10Tet virus. C57BL/6 mice were
i.n. infected, and the extent of splenomegaly, the extent of ex
vivo reactivation of latently infected splenocytes, and the viral
genomic load in the spleen were determined 17 days after
infection. There was no significant difference in the spleen
weight (Fig. 8B), in the frequency of ex vivo reactivation (1 in
10.510 and 1 in 4.176) (Fig. 8C), and in the viral genomic load
(Fig. 8D) between parental virus and the OriLytM10Tet
virus, respectively, while the M10Tet mutant showed re-
duced fitness for all parameters. Thus, ectopic insertion of the
oriLyt completely restored the phenotype of the M10Tet
mutant for all three latency parameters.
A mutant with a deletion which affects the oriLyt exclusively,
but leaves the M10a-c coding sequences intact (201nt mu-
tant), shows the same phenotype as the M10Tet mutant.
The result that ectopic insertion of the oriLyt in the M10Tet
mutant completely restored the phenotype already suggested
that the observed phenotype of the M10Tet mutant is due
to mutation of the oriLyt and not of putative protein coding
sequences within the M10a-c region. To further confirm this,
we analyzed a mutant with a deletion which renders the oriLyt
nonfunctional but leaves the M10a-c coding region intact. The
construction and characterization of this mutant, lacking nu-
cleotide positions 101530 to 101731 (201nt) (schematically
shown in Fig. 1A, bottom), have been described in detail pre-
viously (3). In the previous work, we had also demonstrated
that the 201nt mutant displays a slight replication deficit in
cell culture, just as the M10Tet mutant does. However, the
in vivo phenotype had not been investigated yet. Therefore, we
analyzed here the in vivo phenotype of the 201nt mutant and
compared it to the phenotype of the M10Tet mutant. The
201nt mutant showed a reduction in lytic replication in
the lung after i.n. infection to exactly the same extent as the
M10Tet mutant did (Fig. 3A). In addition, all latency pa-
rameters measured (spleen weight, ex vivo reactivation of la-
tently infected splenocytes, and viral genomic load in the
spleen) were equally reduced after infection with the 201nt
mutant, as they were after infection with the M10Tet mu-
tant (Fig. 4A to C). These data do further support our conclu-
sion that the phenotype caused by mutation of the M10 locus
is due to mutation of the oriLyt and not due to mutation of
putative protein coding sequences within the M10a-c region.
DISCUSSION
While the function of several MHV-68-specific genes has
been elucidated, the function of M10a-c has not been investi-
gated so far. The M10 locus has initially been predicted to
include three overlapping open reading frames (M10a-c) (29).
In addition, the M10 locus contains an oriLyt (8) and a repet-
itive region termed the 100-bp repeat region. The latter region
has recently been described as a ligand for the induction of
type I interferon (23). In this study, we investigated the func-
tion of the M10 locus during lytic and latent infections of mice
with MHV-68 by analyzing mutant viruses with deletions in the
M10 locus, either affecting both the predicted coding region
for M10a-c and the oriLyt or the oriLyt only. While the mu-
tants were slightly attenuated with regard to lytic replication in
cell culture, they showed severe growth defects in vivo. Both
lytic replication and latency amplification were strongly re-
duced in mice infected with the mutant viruses. In contrast, a
revertant virus in which both the M10a-c coding region and the
oriLyt were reverted to those of the wild type and a virus with
an ectopic insertion of the oriLyt which restores the function of
the oriLyt but not the M10a-c coding region grew very similarly
to the parental wild-type virus both in vitro and in vivo. Thus,
we propose that mutation of the oriLyt, and not mutation of
putative protein coding sequences within the M10a-c region, is
responsible for the observed phenotype. This is also consistent
with our failure to demonstrate expression of a protein(s) from
the M10 region (data not shown). Although a recent report
considered M10a-c unlikely to code for proteins (21), we none-
theless undertook two different approaches to detect potential
proteins encoded by the M10 region, as follows: (i) two poly-
clonal rabbit antisera were raised against two synthetic pep-
tides (GNRGDGAPERGSG and PGARERAARPGVR)
from the M10 region, and (ii) a recombinant MHV-68, in
which the product of the M10a open reading frame was C-
terminally tagged by a hemagglutinin (HA) tag, was con-
structed. With the polyclonal rabbit antisera, Western blots
were performed with lysates or supernatants from lytically in-
fected NIH 3T3 cells at various times after infection and also
from the latently infected cell line S11 (27), with the latter cells
either left untreated or treated with tetradecanoyl phorbol
acetate to induce the lytic cycle. To detect a potential HA-
tagged M10a protein, NIH 3T3 cells were infected with the
recombinant MHV-68-M10aHA-tag, and Western blots (with
or without preceding immunoprecipitation) were performed
FIG. 7. Replication in cell culture. NIH 3T3 cells were infected at
an MOI of 0.1 with the indicated viruses. Cells were harvested at
different time points after infection, and titers were determined on
BHK-21 cells. Data shown are the means  standard deviations from
two independent experiments.
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with lysates or supernatants from various times after infection.
Neither with the peptide-specific sera nor with a HA-specific
antibody could expression of M10 proteins be detected (data
not shown). Clearly, we cannot formally exclude protein ex-
pression; however, the data are in accordance with a report
which considered M10a-c rather unlikely to code for proteins
(21). While protein expression has never been demonstrated
from the M10 locus, expression of mRNAs was shown by
others by microarray and/or reverse transcription-PCR assays
(4, 11).
In contrast to our observations, it has recently been reported
that MHV-68 BACs with mutations in or close to the 100-bp
region are unable to produce progeny virions (23). Specifically,
transfection of cells with BACs with transposon insertions at
nucleotide positions 100952 or 101278 did not lead to virus
production. In contrast to our mutants, those mutants were
FIG. 8. Ectopic complementation of the oriLyt restores the phenotype of the M10Tet mutant. C57BL/6 mice were infected i.n. with 5  104
PFU of the indicated viruses. (A) Lytic lung titer. At day 6 after infection, lungs were harvested, and virus titers were determined from organ
homogenates by plaque assay on BHK-21 cells. Each symbol represents an individual mouse, and the bars represent the means. The data are
compiled from two independent experiments. The asterisk indicates a statistically significant difference (P  0.004 [parental virus versus
M10Tet] and P  0.016 [M10Tet versus OriLytM10Tet]). (B) Splenomegaly; (C) ex vivo reactivation of splenocytes; (D) viral genomic
load in the spleen. At day 17 after infection, spleens were harvested, and the spleen weights were taken. Single splenocyte suspensions were
prepared and analyzed in the ex vivo reactivation assay or used for DNA isolation for real-time PCR analysis. Data shown in panel B are the
means standard deviations of nine mice per group, compiled from three independent experiments. The asterisk indicates a statistically significant
difference (P  2.5  10	6 [parental virus versus M10Tet] and P  0.0029 [M10Tet versus OriLytM10Tet]). Data shown in panel C are
the means standard errors of the means pooled from three independent experiments. In each experiment, splenocytes from three mice per group
were pooled. Serial dilutions of live, intact splenocytes were plated on NIH 3T3 indicator cells in parallel with samples that were mechanically
disrupted to distinguish between virus reactivation from latency and preformed infectious virus. No preformed infectious virus was detected with
any of the viruses analyzed (data not shown). The dashed line in panel C indicates the point of 63.2% Poisson distribution, determined by nonlinear
regression, which was used to calculate the frequency of cells reactivating lytic replication. To calculate significance, frequencies of reactivation
events were statistically analyzed by paired t test for all cell dilutions. The statistical significance is indicated by P values of 0.0177 (parental virus
versus M10Tet) and 0.004 (M10Tet versus OriLytM10tet). In panel D, each symbol represents an individual mouse, and the bars
represent the means. The data are compiled from three independent experiments. The asterisk indicates a statistically significant difference (P 
0.001 [parental virus versus M10Tet] and P  0.008 [M10Tet versus OriLytM10Tet]).
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generated by transposon mutagenesis, which does not lead to
the deletion of viral sequences but to an additional insertion of
a 1.3-kb transposon sequence. Importantly, construction of
revertant viruses was not reported. Thus, it is possible that the
presence of the large transposon insertion and/or unwanted
changes elsewhere in the genome which might have occurred
during the mutagenesis procedure are responsible for the ob-
served differences. In our hands, infectious virus from two
different BAC mutants with deletions in the M10 region could
be reconstituted, and both mutants showed comparable phe-
notypes. In addition, the generation of a revertant virus clearly
demonstrated that the observed phenotype of the correspond-
ing mutant is due to the deletion in the M10 region and not to
rearrangements outside of the mutated region.
Consistent with our previous findings (3), the mutants were
slightly attenuated only with regard to lytic replication in cell
culture. Obviously, the remaining second oriLyt is sufficient for
efficient lytic replication in fibroblasts in vitro. In contrast, in
vivo, lytic replication was strongly reduced in mice infected
with the mutant viruses, suggesting that the oriLyt require-
ments for lytic replication may be different in vitro and in vivo.
Of note, latency amplification was also affected. We hypothe-
size that virus reactivation, subsequent lytic replication, and
reinfection contribute to the amplification of latency. Consis-
tent with this hypothesis is the suggestion by others that ongo-
ing productive replication and virus reactivation may reseed
latency reservoirs, thereby increasing the level of latently in-
fected cells (14, 33).
Taking these results together, we conclude that the M10
locus plays an important role during infection of mice with
MHV-68 and that mutation of the oriLyt but not mutation of
putative protein coding sequences within the M10 region crit-
ically affects both lytic and latent infections in vivo.
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